SCLX Company Profile and Key Details
NASDAQ : SCLX
Scilex
$8.07
0.26+3.33%
At Close 4:00 PM$7.70
−0.37-4.58%
After-Market 05:00 PM58.15
ESG ScoreESG Rating
Price Chart
Stock Price Today
Scilex Holding Company (SCLX) stock surged +3.33%, trading at $8.07 on NASDAQ, up from the previous close of $7.81. The stock opened at $7.61, fluctuating between $7.03 and $8.85 in the recent session.
Stock Snapshot
7.81
Prev. Close
68.52M
Market Cap
7.03
Day Low
-0.21
P/E Ratio
-38.95
EPS (TTM)
-0.21
Cash Flow per Share
7.61
Open
8.49M
Number of Shares
8.85
Day High
78.54%
Free Float in %
-1.73
Book Value
2.3M
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 06, 2026 | 7.61 | 8.85 | 7.03 | 8.07 | 2.3M |
| Jul 02, 2026 | 7.93 | 8.49 | 7.69 | 7.81 | 60.23K |
| Jul 01, 2026 | 7.77 | 8.46 | 7.75 | 7.88 | 43.49K |
| Jun 30, 2026 | 7.75 | 7.90 | 7.46 | 7.80 | 57.36K |
| Jun 29, 2026 | 7.15 | 7.80 | 7.11 | 7.80 | 48.29K |
| Jun 26, 2026 | 7.00 | 7.48 | 6.92 | 7.11 | 34.64K |
| Jun 25, 2026 | 6.80 | 7.50 | 6.68 | 7.09 | 68.54K |
| Jun 24, 2026 | 6.80 | 7.08 | 6.60 | 6.86 | 30.8K |
| Jun 23, 2026 | 6.87 | 7.05 | 6.69 | 6.88 | 28.42K |
| Jun 22, 2026 | 7.22 | 7.32 | 6.79 | 6.87 | 71.4K |
| Jun 18, 2026 | 6.81 | 7.47 | 6.52 | 7.47 | 81.06K |
| Jun 17, 2026 | 5.71 | 7.14 | 5.53 | 6.94 | 181.67K |
| Jun 16, 2026 | 6.38 | 6.70 | 5.41 | 5.88 | 313.22K |
| Jun 15, 2026 | 8.48 | 8.59 | 7.91 | 7.95 | 65.16K |
| Jun 12, 2026 | 8.62 | 8.99 | 8.20 | 8.50 | 121.24K |
| Jun 11, 2026 | 8.30 | 9.23 | 7.92 | 8.70 | 91.4K |
| Jun 10, 2026 | 6.95 | 8.80 | 6.95 | 8.80 | 147.19K |
| Jun 09, 2026 | 7.00 | 7.20 | 6.82 | 7.04 | 29.86K |
| Jun 08, 2026 | 7.06 | 7.29 | 6.87 | 6.91 | 42.19K |
| Jun 05, 2026 | 7.76 | 7.76 | 6.82 | 7.00 | 39.18K |
Contact Details
About Company
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.
Company Information
| Employees | 115 |
| Beta | 1.73 |
| Sales or Revenue | $46.74M |
| 5Y Sales Change% | 1.407% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Stock Peers
AMGN
12.82+3.55%
Amgen Inc.$374.15BIIB6.38+3.04%
Biogen Inc.$216.12GILD5.3+4.21%
Gilead Sciences, Inc.$131.27HZNP00
Horizon Therapeutics Public Limited Company$116.30SNY1.53+3.68%
Sanofi$43.16GRFS0.08+1.13%
Grifols, S.A.$7.16MIRA-0.0025-0.26%
MIRA Pharmaceuticals, Inc.$0.94CTOR-0.0239-3.39%
Citius Oncology, Inc.$0.68SCLXW0.02+12.50%
Scilex Holding Company$0.18Company Overview
Scilex Holding Company (NASDAQ:SCLX) closed at $8.50 USD, gaining $0.69 (8.83%) from the previous close of $7.81. The stock is currently mid-range between its 52-week high and low $2.62 and $21.34. With a market capitalization of about $72.18 million, Scilex Holding Company is classified as a micro-cap and shows higher-than-market volatility (beta ~1.73). Key stats such as the average daily volume over the past year has been around 135.96 thousand shares, trading with heavier-than-usual volume. Headquartered in Palo Alto, CA, Scilex Holding Company operates in the Healthcare sector and the Drug Manufacturers - General industry. Led by CEO Henry H. Ji, the company employs approximately 115 people and listed since March 05, 2021. Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain.
Technical Performance
SCLX has shown weak momentum, losing -18.73% over the past week and -14.79% over the past quarter, though year-to-date performance is down -10.74%. Short-term trend indicators are bullishly aligned (SMA20 -3.16%, SMA50 -26.09%, SMA200 -40.27%). The stock’s 14-day RSI is 36.49 (weak momentum), while the ATR of 0.78 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -76.31% below its high and over 125.56% above its low. Average 10-day trading volume of 48.80 thousand shares is below the 3-month average of 90.97 thousand, indicating normal recent market interest.
Valuation Metrics
Scilex Holding Company trades at a P/E ratio of -0.2, slightly below the S&P 500 average, with a price-to-sales ratio of 1.96 and a price-to-book ratio of -0.22 indicating negative book value, which may reflect financial stress. The P/FCF stands at -10.06, also below market averages.
Dividend & Fair Value
Dividend and splits history remains an important factor for investors monitoring long-term returns.
Earnings & Analyst Outlook
Scilex Holding Company generated EPS of -$33.08 over the past year. Five-year average earnings growth is -526.67%. Scilex Holding Company earnings surprise history is a mixed track record. The quarter that ended May 20, 2026, missed forecasts by 1761.84%. The prior quarter beat by 878.72%. Over the last six quarters, Apple has recorded several small beats. These include -46.19% in May 14, 2025.
Shareholding & Insider Activity
Scilex Holding Company has 6.96 million shares outstanding. The public float is 2.92 million shares, elevated short interest at 10.80% of float. This equals 447.39 thousand shares. The short ratio is 2.05 days. Institutional investors hold 15.9% of the float. Insiders own 17.56%. Scilex Holding Co holds 244.45 million shares, Ji Henry has 2.60 million shares and Ma Stephen Hoi has 650.00 thousand shares. Over the past six months, insider transactions show net buying. They sold 650.00 thousand shares across 1 transactions.
Frequently Asked Questions
What is the current Scilex Holding Company (SCLX) stock price?
Scilex Holding Company (NASDAQ: SCLX) stock price is $8.07 in the last trading session. During the trading session, SCLX stock reached the peak price of $8.85 while $7.03 was the lowest point it dropped to. The percentage change in SCLX stock occurred in the recent session was 3.33% while the dollar amount for the price change in SCLX stock was $0.26.
SCLX's industry and sector of operation?
The NASDAQ listed SCLX is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector. Scilex Holding Company designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of SCLX?
Dr. Suketu D. Desai Ph.D.
Chief Technical Officer & Senior Vice President
Chief Technical Officer & Senior Vice President
How SCLX did perform over past 52-week?
SCLX's closing price is 208.58% higher than its 52-week low of $2.62 where as its distance from 52-week high of $21.34 is -62.18%.
How many employees does SCLX have?
Number of SCLX employees currently stands at 115.
Link for SCLX official website?
Official Website of SCLX is: https://www.scilexholding.com
How do I contact SCLX?
SCLX could be contacted at phone 650 516 4310 and can also be accessed through its website. SCLX operates from 960 San Antonio Road, Palo Alto, CA 94303, United States.
How many shares of SCLX are traded daily?
SCLX stock volume for the day was 2.3M shares. The average number of SCLX shares traded daily for last 3 months was 135.96K.
What is the market cap of SCLX currently?
The market value of SCLX currently stands at $68.52M with its latest stock price at $8.07 and 8.49M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep